Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Balding people may have higher heart disease risk.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Low-level laser therapy using near-infrared light may help heart conditions and promote healing by releasing nitric oxide.

People with early-onset hair loss have higher risk of heart issues, so early screening is important.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Lisinopril, a heart medication, probably caused hair loss in a patient, which stopped after switching drugs.

JAGGED1 could help regenerate tissues for bone loss and heart damage if delivered correctly.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

Hibiscus plant extracts may have health benefits like lowering blood pressure and protecting the heart.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Metabolic syndrome in kids and teens is linked to obesity and increases diabetes and heart disease risk; early lifestyle changes are crucial for management.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Lignans and neolignans from plants may help protect against various health issues, including cancer and heart disease.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

The Wnt/β-catenin pathway helps tissue regeneration but can also cause fibrosis, and drugs that inhibit this pathway may aid in healing skin and heart tissues.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Oral minoxidil improves hair growth in men with hair loss, but caution needed for those with heart issues.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.